EPO revokes Esomeprazole patent

[WSJ] [Bloomberg] [Pharmaletter]

EPO last Friday revokes EP1020461, which covers magnesium salt of Esomeprazole and it is divisional patent of EP0652872 (product patent). ‘461 patent revocation status not yet updated in European patent register. ‘461 patent was opposed by many companies including Teva, Hexal, Lupin etc. Esomeprazole’s product patent (‘872) has already been revoked in Europe. Astrazeneca appealed this decision.

… After the patent was granted in 2009, AstraZeneca has enforced this patent in several countries in Europe. We will continue to decide on a case by case basis whether it is appropriate to continue to assert this patent,” the spokeswoman said …

… Several generic drugmakers launched cheap copies of Nexium in Germany in late 2010, and AstraZeneca said in October that a generic had also gone on sale in Spain …

About Guna

Interested to learn things around me
This entry was posted in Patent case and tagged , , . Bookmark the permalink.

1 Response to EPO revokes Esomeprazole patent

  1. Pingback: Does Anyone Want Axanum? | Pharma Marketer

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s